UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1996, Lung biology in health and disease, ISBN 0824794036, Volume 87, xvii, 316
Book
Mycoses, ISSN 0933-7407, 11/2020, Volume 63, Issue 11, pp. 1203 - 1214
Acremonium | infection | pathology | taxonomy | Sarocladium | Invasive Fungal Infections - pathology | Dermatomycoses - drug therapy | Hypocreales - pathogenicity | Humans | Eye Infections - drug therapy | Acremonium - drug effects | Blood - microbiology | Eye Infections - microbiology | Osteomyelitis - drug therapy | Antifungal Agents - therapeutic use | Respiratory Tract Infections - microbiology | Peritonitis - microbiology | Endocarditis - microbiology | Invasive Fungal Infections - drug therapy | Mycoses - veterinary | Central Nervous System Infections - microbiology | Drug Resistance, Fungal | Hypocreales - classification | Arthritis - microbiology | Onychomycosis - drug therapy | Acremonium - isolation & purification | Acremonium - classification | Voriconazole - therapeutic use | Respiratory Tract Infections - drug therapy | Opportunistic Infections - veterinary | Animals | Osteomyelitis - microbiology | Acremonium - pathogenicity | Mycoses - pathology | Opportunistic Infections - drug therapy | Arthritis - drug therapy | Mycoses - drug therapy | Endocarditis - drug therapy | Hypocreales - drug effects | Peritonitis - drug therapy | Mycetoma - drug therapy | Onychomycosis - microbiology | Opportunistic Infections - pathology | Central Nervous System Infections - drug therapy | Hypocreales - isolation & purification | Fungi | Health aspects | Infections | Prognosis | Voriconazole | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9738, pp. 367 - 387
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug addiction | General aspects | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Addictive behaviors | Biological and medical sciences | Medical sciences | HIV Infections - epidemiology | Humans | Drug Resistance, Bacterial | Narcotics - therapeutic use | Criminal Law | Anti-HIV Agents - administration & dosage | Hepatitis, Viral, Human - epidemiology | Drug Interactions | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Tuberculosis - drug therapy | Anti-HIV Agents - therapeutic use | HIV Infections - mortality | Substance-Related Disorders - mortality | Antitubercular Agents - therapeutic use | Mental Disorders - epidemiology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Comorbidity | AIDS-Related Opportunistic Infections - drug therapy | Evidence-Based Medicine | Narcotics - administration & dosage | Medication Adherence | Mental Disorders - drug therapy | AIDS-Related Opportunistic Infections - epidemiology | Bacterial Infections - epidemiology | HIV Infections - drug therapy | Substance-Related Disorders - drug therapy | Hepatitis, Viral, Human - drug therapy | Prisoners | Prevention | Complications and side effects | Drug addicts | Research | Drug therapy | Health aspects | HIV infection | Mental illness | Risk factors | Index Medicus | Abridged Index Medicus | Cardiovascular diseases
Journal Article
5.
Full Text
Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies?
Trends in microbiology (Regular ed.), ISSN 0966-842X, 2017, Volume 25, Issue 6, pp. 467 - 479
Internal Medicine | Novel compounds | Antimicrobial therapy | Antibiotics | Cell wall | Enterococcus | Enterococcus faecalis | Cell Membrane | Nisin | Humans | Cross Infection | Depsipeptides | Vancomycin | Review | Drug Discovery | Anti-Infective Agents | Journal Article | Cell Wall | Microbial Sensitivity Tests | Enterococcus faecium | Anti-Bacterial Agents | Gram-Positive Bacterial Infections | Animals | Drug Resistance, Multiple, Bacterial | Models, Animal | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Enterococcus faecium - drug effects | Enterococcus faecalis - drug effects | Depsipeptides - pharmacology | Vancomycin - chemistry | Cell Wall - drug effects | Anti-Bacterial Agents - chemistry | Anti-Infective Agents - chemistry | Vancomycin - pharmacology | Gram-Positive Bacterial Infections - microbiology | Cell Membrane - drug effects | Anti-Infective Agents - therapeutic use | Nisin - chemistry | Anti-Bacterial Agents - classification | Nisin - pharmacology | Cross Infection - microbiology | Anti-Bacterial Agents - pharmacology | Enterococcus - drug effects | Gram-Positive Bacterial Infections - drug therapy | Anti-Infective Agents - classification | Drug Resistance, Multiple, Bacterial - drug effects | Drug resistance in microorganisms | Bacterial infections | Analysis | Physiological aspects | Bacteria | Antibacterial agents | Health aspects | Organic acids | Medical care, Cost of | Enzymes | Drug discovery | Health care | Nosocomial infection | Animal models | Lipoteichoic acid | Gram-positive bacteria | Opportunist infection | Biosynthesis | Infections | Drug resistance | Drug development | Antiinfectives and antibacterials | Antibiotic resistance | Alanine racemase | Alanine | Antimicrobial agents | Morbidity | Mode of action | Hospitals | Inhibitors | Acids | Oxazolidinones | Lipopeptides | Sortase | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 07/2016, Volume 316, Issue 2, pp. 191 - 210
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | HIV-1 | HIV Infections - prevention & control | AIDS-Related Opportunistic Infections | Anti-Retroviral Agents - therapeutic use | Prognosis | Viremia | Humans | Middle Aged | Male | CD4 Lymphocyte Count | Viral Load | Pre-Exposure Prophylaxis | Pregnancy | Young Adult | Treatment Failure | Adolescent | Post-Exposure Prophylaxis | Adult | Female | HIV Infections - drug therapy | Aged | Drug Therapy, Combination | Disease prevention | Antiretroviral drugs | Adults | Inhibitor drugs | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2010, Volume 362, Issue 8, pp. 697 - 706
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antitubercular Agents - adverse effects | Follow-Up Studies | Humans | Middle Aged | Male | RNA, Viral - blood | Viral Load | Young Adult | Tuberculosis - drug therapy | AIDS-Related Opportunistic Infections - mortality | Adult | Female | HIV Infections - mortality | Drug Therapy, Combination | Tuberculosis - mortality | Drug Administration Schedule | AIDS-Related Opportunistic Infections - drug therapy | Anti-Retroviral Agents - adverse effects | Kaplan-Meier Estimate | CD4 Lymphocyte Count | HIV - isolation & purification | Patient Compliance - statistics & numerical data | Anti-Retroviral Agents - administration & dosage | HIV Infections - complications | Antitubercular Agents - administration & dosage | HIV - genetics | HIV Infections - drug therapy | Usage | Care and treatment | Tuberculosis | Health aspects | Antiretroviral drugs | Fatalities | Infections | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 16, pp. 1471 - 1481
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Drug Administration Schedule | Follow-Up Studies | Humans | AIDS-Related Opportunistic Infections - drug therapy | Anti-Retroviral Agents - adverse effects | Kaplan-Meier Estimate | Tuberculosis - complications | Male | CD4 Lymphocyte Count | Viral Load | Anti-Retroviral Agents - administration & dosage | Tuberculosis - drug therapy | HIV Infections - complications | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Antitubercular Agents - therapeutic use | Care and treatment | Tuberculosis | Patient outcomes | Antitubercular agents | Dosage and administration | Drug therapy | HIV infection | Comorbid patients | Cell survival | Mortality